Chemical Works of Gedeon Richter Plc Logo

Chemical Works of Gedeon Richter Plc

Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.

RICHT | BUD

Overview

Corporate Details

ISIN(s):
HU0000067624 (+3 more)
LEI:
549300J6ZJW5IH4WEE46
Country:
Hungary
Address:
GYOMROI UT 19-21, 1103 BUDAPEST
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Chemical Works of Gedeon Richter Plc. is a multinational, vertically integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of medicinal products. The company's core therapeutic areas include women's health, central nervous system disorders, and cardiovascular diseases, with additional activity in oncology. Its portfolio consists of original research drugs, active pharmaceutical ingredients (APIs), and generic medicines. Founded in 1901, Gedeon Richter focuses on delivering high-value therapies to improve the quality of life for patients globally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 226.8 KB
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
English 321.4 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 192.9 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
English 295.6 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 229.2 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
English 199.8 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
English 179.1 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
Hungarian 238.5 KB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
Hungarian 1.4 MB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
English 1.4 MB
2025-10-31 14:11
Regulatory News Service
Voting rights, registered capital
Hungarian 244.7 KB
2025-10-31 14:11
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
English 207.0 KB
2025-10-09 10:32
Regulatory News Service
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
Hungarian 1.4 MB
2025-10-09 10:32
Interim Report
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
English 1.4 MB
2025-09-30 14:34
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
Hungarian 243.0 KB

Automate Your Workflow. Get a real-time feed of all Chemical Works of Gedeon Richter Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chemical Works of Gedeon Richter Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chemical Works of Gedeon Richter Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America
NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America
NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America
NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America
NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America
NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America
NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden
NEWBRY

Talk to a Data Expert

Have a question? We'll get back to you promptly.